Study, published in The Lancet Respiratory Medicine, has revealed that a drug called benralizumab - administered as an ...
The study, called the ABRA trial, was led by King’s College London researchers and published in The Lancet Respiratory ...
The first new treatment for asthma attacks in 50 years is a drug already available—and it’s 4x more effective than steroid ...
London scientists have created a “game-changing” new treatment for asthma attacks that can reduce the need for further ...
It is already used as a recurring treatment for severe asthma in low doses. However, the trial found that a single higher ...
Benralizumab is what’s known as a monoclonal antibody, which replicates properties of a normal antibody produced by the ...
Benralizumab is a monoclonal antibody that targets specific white blood cells, called eosinophils, to reduce lung ...
The IL-5 inhibitor is already available under the Fasenra brand name for maintenance use in severe eosinophilic asthma, but a ...
A UK study has shown that a drug currently used to treat severe asthma could be re-purposed for use in emergency settings, ...
Benralizumab, a monoclonal antibody, is already used for the long-term management of eosinophilic asthma, with studies still evaluating the effect of long-term management in eosinophilic COPD.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback